BioSpace News Archive

ATCC, the world’s premier biological materials management and standards organization, announced it has promoted Teri Sellars to the position of Vice President, Human Resources and Chief People Officer.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that CEO, Timothy C. Rodell , MD, is scheduled to present to a live audience at the LD Micro 500 virtual investor conference on Thursday, September

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced that it has completed the acquisition of Statera Spine, a pre-operative diagnostics and quantitative data software solution that improves treatment decisions for spine patients. Statera Spine is a software enabled spine imaging analytics company dedicated to providin

- New U.S. Patent No. 10,730,826 provides additional composition of matter protection for atuzaginstat (COR388) - The ‘826 patent extends the patent term for atuzaginstat to 2037, with a possible patent term extension of up to an additional five years

UroGen Pharma Announces Update on the Phase 2 Trial of an RTGel™ Hydrogel Formulation in Combination with BOTOX ® (onabotulinumtoxinA) Intravesical Instillation for Overactive Bladder and Urinary Incontinence Trial Did Not Meet Primary Endpoint Believed to be the Result of BOTOX Not Effectively Permeating the Urothelium RTGel Delivered Treatment to the Bladder as Expected with Dwell Time of Up to 10 Hours UroGen and AbbVie will Continue

Translational Imaging Innovations (TII), Inc., a North Carolina-based company accelerating the development of diagnostic biomarkers of eye disease through its novel image management and analytics software has been awarded a $1.5M Direct-to-Phase II Small Business Innovation Research (SBIR) award by the National Eye Institute of the National Institutes of Health.

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it will receive a milestone payment from GlaxoSmithKline (GSK) triggered by European Commission conditional marketing authorisation for GSK’s BLENREP™ (belantamab mafodotin), an antibody-drug conjugate (ADC) targeting B-cell maturation antigen (BCMA) that utilizes Seattle Genetics’ proprietary technology. BLENREP was developed and will be commercialized by GSK. In

Today, MANA RBM announced the launch of new remote trial management and oversight capabilities in collaboration with select vendor partners, Bio-Optronics Inc., TransPerfect’s Trial Interactive, and Integrated Clinical Systems.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by the New England Journal of Medicine (NEJM) of results from the Protocol 5 study (DCLP5) of the International Diabetes Closed Loop (iDCL) trial. Results demonstrated increased time spent in range (70-180 mg/dL) in children ages 6 to 13 years old using the t:slim X2™ insulin pump with Control-IQ

Milestone Scientific Inc. today announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020.